Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

YMAB Y-mAbs Therapeutics, Inc.

交易中 12-27 13:45:06 EST

7.90

-0.10

-1.25%

最高8.02	最低7.66	成交量21.27万
今开7.91	昨收8.00	日振幅4.50%
总市值3.54亿	流通市值2.14亿	总股本4,479万
成交额165.83万	换手率0.79%	流通股本2,707万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"YMAB","market":"US","secType":"STK","nameCN":"Y-mAbs Therapeutics, Inc.","latestPrice":7.9,"timestamp":1735325076705,"preClose":8,"halted":0,"volume":212697,"delay":0,"floatShares":27074620,"shares":44789076,"eps":-0.542171,"marketStatus":"交易中","change":-0.1,"latestTime":"12-27 13:45:06 EST","open":7.91,"high":8.02,"low":7.66,"amount":1658268.2746269,"amplitude":0.045,"askPrice":7.94,"askSize":300,"bidPrice":7.87,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-0.542171,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1735333200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1537502400000,"exchange":"NASDAQ","adjPreClose":8,"preHourTrading":{"tag":"盘前","latestPrice":7.91,"preClose":8,"latestTime":"08:48 EST","volume":234,"amount":1851.0599016,"timestamp":1735307327863},"postHourTrading":{"tag":"盘后","latestPrice":8,"preClose":8,"latestTime":"19:37 EST","volume":3075,"amount":24606.04,"timestamp":1735259838171},"volumeRatio":0.653004,"impliedVol":0.2181,"impliedVolPercentile":0.0516},"requestUrl":"/m/hq/s/YMAB","defaultTab":"news","newsList":[{"id":"2493472717","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘急速下挫5.02%报8.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493472717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493472717?lang=zh_cn&edition=full","pubTime":"2024-12-21 02:28","pubTimestamp":1734719319,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日02时28分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅下跌5.02%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Psyence Biomedical Ltd C/Wts 25/01/2029、Abpro Holdings, Inc涨幅较大，Psyence Biomedical Ltd.、Aptose Biosciences, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为2614.54%、484.50%、118.42%，振幅较大的相关个股有Abpro Holdings, Inc、Abpro Holdings Inc C/Wts 12/11/2029 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为173.15%、163.64%、108.00%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221022839ab87c495&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221022839ab87c495&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","YMAB","LENZ"],"gpt_icon":0},{"id":"2491019694","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大涨17.39%报11.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491019694","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491019694?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359505,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅拉升17.39%。截至发稿，该股报11.07美元/股，成交量2.7264万股，换手率0.06%，振幅1.76%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Tonix Pharmaceuticals Holding Corp.、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为29.74%、29.18%、22.11%，振幅较大的相关个股有Tonix Pharmaceuticals Holding Corp.、Genprex, Inc.、X4制药，振幅分别为13.80%、8.62%、8.61%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223145a1f342c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223145a1f342c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YMAB","LENZ","BK4139"],"gpt_icon":0},{"id":"2489840457","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘大幅上涨5.88%报10.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489840457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489840457?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:36","pubTimestamp":1733409414,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时36分，Y-Mabs Therapeutics, Inc.股票出现异动，股价快速拉升5.88%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Protara Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Psyence Biomedical Ltd.、Protara Therapeutics, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1859.16%、263.12%、207.82%，振幅较大的相关个股有Protara Therapeutics, Inc.、Psyence Biomedical Ltd.、Alx Oncology Holdings Inc.，振幅分别为38.70%、29.76%、13.14%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223654971be1ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223654971be1ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","YMAB"],"gpt_icon":0},{"id":"2488960319","title":"Y-Mabs Therapeutics, Inc.盘中异动 大幅下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488960319","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488960319?lang=zh_cn&edition=full","pubTime":"2024-12-03 00:01","pubTimestamp":1733155300,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日00时01分，Y-Mabs Therapeutics, Inc.股票出现异动，股价大幅下挫5.03%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Senti Biosciences, Inc.、Revelation Biosciences, Inc.、Cabaletta Bio, Inc.较为活跃，换手率分别为1882.08%、240.80%、28.09%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为481.02%、64.17%、45.18%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000140971b3170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203000140971b3170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","YMAB"],"gpt_icon":0},{"id":"2486873063","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘急速拉升5.11%报11.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486873063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486873063?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:12","pubTimestamp":1732720340,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时12分，Y-Mabs Therapeutics, Inc.股票出现异动，股价急速上涨5.11%。截至发稿，该股报11.32美元/股，成交量2.1953万股，换手率0.05%，振幅5.80%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127231220a25a040c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127231220a25a040c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","YMAB","LENZ"],"gpt_icon":0},{"id":"2486038271","title":"Y-Mabs Therapeutics, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038271?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:36","pubTimestamp":1732545391,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时36分，Y-Mabs Therapeutics, Inc.股票出现异动，股价大幅上涨5.00%。截至发稿，该股报10.93美元/股，成交量2.1193万股，换手率0.05%，振幅0.00%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为89.49%、65.21%、41.13%，振幅较大的相关个股有Werewolf Therapeutics, Inc.、Anixa Biosciences, Inc.、Jasper Therapeutics, Inc.，振幅分别为105.79%、105.63%、105.53%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522363198e44682&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522363198e44682&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","YMAB"],"gpt_icon":0},{"id":"2483880476","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大跌5.12%报12.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483880476?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:38","pubTimestamp":1731595083,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时38分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅下跌5.12%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Elevai Labs, Inc.、Calidi Biotherapeutics, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为1654.26%、23.56%、16.26%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Elevai Labs, Inc.、Pds Biotechnology Corporation，振幅分别为75.00%、38.46%、26.13%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223804971a68ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114223804971a68ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YMAB","LENZ","BK4139"],"gpt_icon":0},{"id":"2481104379","title":"Y-Mabs Therapeutics, Inc.股价重挫16.27% 市值跌9441.46万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481104379","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481104379?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:32","pubTimestamp":1731076339,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时32分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅下跌16.27%。截至发稿，该股报13.02美元/股，成交量1.0632万股，换手率0.02%，振幅5.02%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Fortrea Holdings Inc.、Tenaya Therapeutics, Inc.、Rigel Pharmaceuticals, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为379.56%、16.37%、13.94%，振幅较大的相关个股有Anebulo Pharmaceuticals, Inc.、Rigel Pharmaceuticals, Inc.、Cardiff Oncology, Inc.，振幅分别为14.96%、14.18%、13.69%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822321995bdef0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110822321995bdef0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","YMAB","LENZ"],"gpt_icon":0},{"id":"2481936756","title":"Y-Mabs Therapeutics, Inc.盘中异动 股价大涨5.03%报15.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481936756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481936756?lang=zh_cn&edition=full","pubTime":"2024-11-07 01:46","pubTimestamp":1730915213,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日01时46分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅上涨5.03%。截至发稿，该股报15.86美元/股，成交量11.746万股，换手率0.26%，振幅4.24%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107014653971a4d90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107014653971a4d90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","YMAB"],"gpt_icon":0},{"id":"2481074376","title":"Y-mAbs Therapeutics Inc 预计每股亏损16美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481074376","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481074376?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:14","pubTimestamp":1730902445,"startTime":"0","endTime":"0","summary":"Y-mAbs Therapeutics Inc 预计每股亏损16美分 - 财报前瞻Y-mAbs Therapeutics Inc YMAB.OQ YMAB.O将于11月8日公布截至2024年9月30日的财报，预计该公司的季度收入将有所增长。LSEG 分析师对 Y-mAbs Therapeutics Inc 的平均预期是每股亏损 16 美分。华尔街对 Y-mAbs Therapeutics Inc 的 12 个月目标价中位数为 21.50 美元，高于其上次收盘价 15.10 美元。11月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241106:nL4S3MD2F2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YMAB"],"gpt_icon":0},{"id":"2467497418","title":"Y-Mabs Therapeutics, Inc.盘中异动 急速下跌5.39%报13.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467497418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467497418?lang=zh_cn&edition=full","pubTime":"2024-09-16 22:25","pubTimestamp":1726496755,"startTime":"0","endTime":"0","summary":"北京时间2024年09月16日22时25分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速下跌5.39%。截至发稿，该股报13.00美元/股，成交量4.9667万股，换手率0.11%，振幅5.49%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Nucana Plc、Surrozen Inc C/Wts 01/08/2031 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nucana Plc、Dermata Therapeutics, Inc.、Exicure, Inc.较为活跃，换手率分别为1378.35%、1350.65%、835.87%，振幅较大的相关个股有Nucana Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Exicure, Inc.，振幅分别为61.02%、47.50%、40.62%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240916222555ab64017e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240916222555ab64017e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YMAB","BK4139","LENZ"],"gpt_icon":0},{"id":"2460928885","title":"Y-Mabs Therapeutics, Inc.盘中异动 早盘股价大涨5.60%报13.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460928885","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460928885?lang=zh_cn&edition=full","pubTime":"2024-08-20 23:19","pubTimestamp":1724167199,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日23时19分，Y-Mabs Therapeutics, Inc.股票出现异动，股价大幅上涨5.60%。截至发稿，该股报13.19美元/股，成交量11.5855万股，换手率0.26%，振幅5.00%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。消息层面，截至23时20分，Y-Mabs Therapeutics, Inc.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082023200198e358fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082023200198e358fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","YMAB","BK4139"],"gpt_icon":0},{"id":"2460717796","title":"Y-Mabs Therapeutics, Inc.2024财年第二财季实现净利润-9.25百万美元，同比减少46.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460717796","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460717796?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:02","pubTimestamp":1723996943,"startTime":"0","endTime":"0","summary":"8月19日，Y-Mabs Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-9.25百万美元，同比减少46.83%；其中营业收入为22.80百万美元，同比增加9.88%，每股基本收益为-0.21美元。从资产负债表来看，Y-Mabs Therapeutics, Inc.总负债48.70百万美元，其中短期债务842000.00美元，资产负债比为0.03，流动比率为0.03。机构评级：截至2024年8月19日，当前有10家机构对Y-Mabs Therapeutics, Inc.目标价做出预测，其中目标均价为20.80美元，其中最低目标价为11.00美元，最高目标价为26.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900024295a38540&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900024295a38540&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","YMAB"],"gpt_icon":0},{"id":"2459109666","title":"Y-Mabs Therapeutics, Inc.盘中异动 临近午盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459109666","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459109666?lang=zh_cn&edition=full","pubTime":"2024-08-14 23:34","pubTimestamp":1723649691,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日23时34分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅拉升5.08%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。其相关个股中，Unicycive Therapeutics, Inc.、Zura Bio Limited C/Wts 、Newamsterdam Pharma Co Nv C/Wts 涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Tc Biopharm  Plc较为活跃，换手率分别为87.89%、75.53%、66.81%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814233451ab5db112&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814233451ab5db112&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","YMAB"],"gpt_icon":0},{"id":"2459133087","title":"Y-Mabs Therapeutics, Inc.盘中异动 下午盘大幅上涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2459133087","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459133087?lang=zh_cn&edition=full","pubTime":"2024-08-14 02:38","pubTimestamp":1723574317,"startTime":"0","endTime":"0","summary":"北京时间2024年08月14日02时38分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速上涨5.03%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Psyence Biomedical Ltd C/Wts 25/01/2029、Orgenesis Inc.涨幅较大，Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃，换手率分别为149.92%、137.55%、40.92%，振幅较大的相关个股有冠科美博、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Os Therapies Incorporated，振幅分别为78.40%、49.54%、42.38%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814023838af974516&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240814023838af974516&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","YMAB"],"gpt_icon":0},{"id":"2458698698","title":"Y-Mabs Therapeutics, Inc.股价重挫14.01% 市值跌5926.57万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458698698","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458698698?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469479,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分，Y-Mabs Therapeutics, Inc.股票出现异动，股价快速下跌14.01%。截至发稿，该股报9.64美元/股，成交量13.3333万股，换手率0.30%，振幅2.96%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大，60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为35.72%、18.82%、8.53%，振幅较大的相关个股有Sangamo Therapeutics, Inc.、Azitra Inc、Oragenics Inc.，振幅分别为21.57%、12.38%、11.79%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131199592945f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131199592945f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","YMAB","LENZ"],"gpt_icon":0},{"id":"2458551058","title":"Y-mAbs Therapeutics Inc   预计每股亏损13美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458551058","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458551058?lang=zh_cn&edition=full","pubTime":"2024-08-10 02:34","pubTimestamp":1723228451,"startTime":"0","endTime":"0","summary":"   * Y-mAbs Therapeutics Inc    将于8月12日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于纽约的公司的营收将从去年同期的2075万美元增长10.9%，达到2301.9万美元。* LSEG 分析师对 Y-mAbs Therapeutics Inc 的平均预期是每股亏损 13 美分。* 华尔街对 Y-mAbs Therapeutics Inc 的 12 个月目标价中位数为 22.00 美元，高于其最新收盘价 11.33 美元。8月9日 - 以前季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","YMAB"],"gpt_icon":0},{"id":"2457048318","title":"Y-mAbs Therapeutics Inc   预计每股亏损13美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457048318","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457048318?lang=zh_cn&edition=full","pubTime":"2024-08-06 19:29","pubTimestamp":1722943768,"startTime":"0","endTime":"0","summary":"   * Y-mAbs Therapeutics Inc    将于8月12日公布截至2024年6月30日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，6位分析师的平均预期显示，这家总部位于纽约的公司的营收将从去年同期的2075万美元增长10.9%，达到2301.9万美元。* LSEG 分析师对 Y-mAbs Therapeutics Inc 的平均预期是每股亏损 13 美分。* 华尔街对 Y-mAbs Therapeutics Inc 的 12 个月目标价中位数为 22.00 美元，高于其上次收盘价 10.76 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YMAB","LENZ"],"gpt_icon":0},{"id":"2456289101","title":"Y-Mabs Therapeutics, Inc.盘中异动 股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456289101","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456289101?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605460,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分，Y-Mabs Therapeutics, Inc.股票出现波动，股价大幅跳水5.15%。截至发稿，该股报11.04美元/股，成交量2904股，换手率0.01%，振幅0.00%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Os Therapies Incorporated涨幅较大，Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃，换手率分别为213.36%、40.49%、16.43%，振幅较大的相关个股有Nuvation Bio Inc.、Xencor, Inc.、Springworks Therapeutics, Inc.，振幅分别为9.01%、8.12%、6.86%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221310096823398&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024080221310096823398&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","YMAB","LENZ"],"gpt_icon":0},{"id":"2453710557","title":"Y-Mabs Therapeutics, Inc.盘中异动 临近收盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453710557","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2453710557?lang=zh_cn&edition=full","pubTime":"2024-07-23 03:51","pubTimestamp":1721677914,"startTime":"0","endTime":"0","summary":"北京时间2024年07月23日03时51分，Y-Mabs Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。Y-Mabs Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.00%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、木薯科学、Apollomics Inc C/Wts 01/04/2028 涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为125.06%、119.83%、89.76%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为76.06%、53.55%、44.07%。Y-Mabs Therapeutics, Inc.公司简介：Y-mAbs Therapeutics Inc 是一家商业化阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723035155aefacf11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240723035155aefacf11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["YMAB","BK4139","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ymabs.com","stockEarnings":[{"period":"1week","weight":-0.0665},{"period":"1month","weight":-0.2572},{"period":"3month","weight":-0.3822},{"period":"6month","weight":-0.3377},{"period":"1year","weight":0.0929},{"period":"ytd","weight":0.173}],"compareEarnings":[{"period":"1week","weight":0.026},{"period":"1month","weight":0.0011},{"period":"3month","weight":0.0523},{"period":"6month","weight":0.105},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.2652}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Y-mAbs Therapeutics, Inc.于2015年4月30日根据特拉华州法律注册成立。该公司是一家后期临床生物制药公司，专注于开发和将用于治疗癌症的新型抗体治疗产品商业化。YY-mAbs Therapeutics, Inc.拥有广泛而先进的产品系列，包括两个关键阶段产品候选物 - 纳西他马和omburtamab-分别针对与GD2和B7-H3相关的肿瘤。该公司正在开发用于治疗患有复发或难治性或R / R，高风险神经母细胞瘤或NB的儿科患者的naxitamab，以及用于治疗患有中枢神经系统或中枢神经系统，软脑膜转移瘤或LM的儿科患者的放射性标记的omburtamab来自NB。NB是在交感神经系统中发展的罕见且几乎完全是小儿的癌症，并且CNS / LM是NB的罕见且通常致命的并发症，其中疾病传播到CNS中的脑膜和脊髓周围的脑膜或脑膜。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.053593},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.024313},{"month":3,"riseRate":0.5,"avgChangeRate":0.092289},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.000439},{"month":5,"riseRate":0.666667,"avgChangeRate":0.141194},{"month":6,"riseRate":0.5,"avgChangeRate":0.041219},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.047585},{"month":8,"riseRate":0.666667,"avgChangeRate":0.061965},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.051525},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.081791},{"month":11,"riseRate":0.714286,"avgChangeRate":0.029491},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.067777}],"exchange":"NASDAQ","name":"Y-mAbs Therapeutics, Inc.","nameEN":"Y-mAbs Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Y-mAbs Therapeutics, Inc.(YMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Y-mAbs Therapeutics, Inc.,YMAB,Y-mAbs Therapeutics, Inc.股票,Y-mAbs Therapeutics, Inc.股票老虎,Y-mAbs Therapeutics, Inc.股票老虎国际,Y-mAbs Therapeutics, Inc.行情,Y-mAbs Therapeutics, Inc.股票行情,Y-mAbs Therapeutics, Inc.股价,Y-mAbs Therapeutics, Inc.股市,Y-mAbs Therapeutics, Inc.股票价格,Y-mAbs Therapeutics, Inc.股票交易,Y-mAbs Therapeutics, Inc.股票购买,Y-mAbs Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Y-mAbs Therapeutics, Inc.(YMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Y-mAbs Therapeutics, Inc.(YMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况